NCT07762443
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
StatusRecruiting
PhasePhase 1
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Eligibility criteria expanded, about 7 words
- Start date changed from estimate of Sep 30, 2026 to Sep 22, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC)
Timeframe: Day1,Day28
Peak Plasma Concentration (Cmax)
Timeframe: Day1,Day28
Arms and interventions
VC005 Tablets Low Dose groupsExperimental
VC005 Tablets High Dose groupsExperimental
Drugs: VC005 tablets
Sites
1 site in 1 country
- The Peking University People's HospitalBeijing, Beijing Municipality, China